Aperistalsis of the Esophagus in Patients with Connective-Tissue Disorders and Raynaud's Phenomenon
- 4 June 1964
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 270 (23) , 1218-1222
- https://doi.org/10.1056/nejm196406042702303
Abstract
EXTENSIVE clinical data have been accumulated during recent years that support the view that scleroderma is a systemic disease. In addition to cutaneous involvement, which remains the cardinal diagnostic feature, widespread visceral lesions are found in the majority of patients with this disorder.Involvement of the gastrointestinal tract is especially common. Since Ehrmann's1 initial observation of dysphagia in a patient with scleroderma, much attention has been directed toward defining the character of the esophageal lesion. Radiographic studies2 , 3 and measurements of intraluminal pressures4 5 6 have shown the primary defect of the So-Called "sclerodermatous" esophagus to be the loss of peristalsis. Despite the . . .Keywords
This publication has 20 references indexed in Scilit:
- The Clinical Significance of Extracellular Material (ECM) in L.E.-Cell PreparationsNew England Journal of Medicine, 1963
- The Clinical Value of Esophageal Motor StudiesPostgraduate Medicine, 1961
- Clinical diagnosis of systemic lupus erythematosusThe American Journal of Medicine, 1958
- A REVIEW OF ROENTGEN FINDINGS IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)The Lancet Healthy Longevity, 1958
- Esophageal Motility in Patients with Scleroderma and Related DiseasesDigestion, 1956
- SYSTEMIC LUPUS ERYTHEMATOSUSMedicine, 1954
- ROENTGEN CHANGES OBSERVED IN GENERALIZED SCLERODERMAA.M.A. Archives of Internal Medicine, 1954
- THE ŒSOPHAGEAL LESION IN SCLERODERMAThe Lancet, 1954
- NATURAL HISTORY OF LUPUS ERYTHEMATOSUS DISSEMINATUSAnnals of Internal Medicine, 1953
- I. Motility of the human esophagus in control subjects and in patients with esophageal disordersThe American Journal of Medicine, 1949